about
Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogensImproving immunization approaches to cholera.Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphologyVaccines against human diarrheal pathogens: current status and perspectivesPhase variable O antigen biosynthetic genes control expression of the major protective antigen and bacteriophage receptor in Vibrio cholerae O1Immunization with cholera toxin B subunit induces high-level protection in the suckling mouse model of cholera.A combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesicles.The NorR regulon is critical for Vibrio cholerae resistance to nitric oxide and sustained colonization of the intestines.Neutrophils are essential for containment of Vibrio cholerae to the intestine during the proinflammatory phase of infection.Production of putative enhanced oral cholera vaccine strains that express toxin-coregulated pilusLipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen.The utility of human challenge studies in vaccine development: lessons learned from cholera.Immunity Provided by an Outer Membrane Vesicle Cholera Vaccine Is Due to O-Antigen-Specific Antibodies Inhibiting Bacterial Motility.The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae.Old foes, new challenges: syphilis, cholera and TB.Cross-protection against Vibrio cholerae infection by monoclonal antibodies against Vibrio vulnificus RtxA1/MARTXVv.A monoclonal antibody that targets the conserved core/lipid A region of lipopolysaccharide affects motility and reduces intestinal colonization of both classical and El Tor Vibrio cholerae biotypes.Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide.Vibrio cholerae O1 secretes an extracellular matrix in response to antibody-mediated agglutination.Vibrio cholerae outer membrane vesicles inhibit bacteriophage infection.
P2860
Q27011190-5D7D4567-6B31-4AFF-86D4-CF588DB3E8D8Q30151668-7D0BBD91-D7EC-47A1-B4BF-8FE5FEC67E28Q30628895-DFF0A918-B152-43A8-82BC-DDA30391F26FQ33578045-27536641-73C0-46B3-BF12-A4C9B9EECAD8Q34426457-E25E7B09-B805-4E60-BC97-38469E2433F3Q34611925-0C3687AF-F8A2-4E34-AC67-292D7C0AB2BBQ35935738-4C20C903-E3EB-4568-82D1-A89D40133104Q35937875-F55AE0FC-B023-4155-946D-FF450A16FA30Q36211171-4F60A5C7-9CB6-442C-8313-AA4A6D7329C4Q36338084-1A58FB01-8063-4F88-B3D9-3D944E68C46AQ36970778-21C17F13-2A56-4E15-BE4E-584FC51B0648Q37523806-62929028-1A97-49BF-BDA4-3BEBC9C2D2BFQ37547002-9F1FB249-9AD2-480A-8EF7-C8ED7B52FB2EQ37563642-350F47F3-2352-44EB-B6FE-1A07B6F81DDDQ38078460-215075A8-4D7F-4679-A0E9-E03BE77571D5Q40422208-512508D0-48F4-4F5E-85A8-09D91F983333Q40489920-F1F7F9D7-4440-4697-9003-6C784DAFF4D8Q41342001-F3EE6D6E-4DF1-48B8-9A28-47828AB68269Q48321872-63DAF35A-A925-46FE-8AE7-9A14E25D9230Q52431608-6D919EEE-852C-49B9-B6B8-A067CCCCFB1E
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Vibrio cholerae: lessons for mucosal vaccine design.
@ast
Vibrio cholerae: lessons for mucosal vaccine design.
@en
Vibrio cholerae: lessons for mucosal vaccine design.
@nl
type
label
Vibrio cholerae: lessons for mucosal vaccine design.
@ast
Vibrio cholerae: lessons for mucosal vaccine design.
@en
Vibrio cholerae: lessons for mucosal vaccine design.
@nl
prefLabel
Vibrio cholerae: lessons for mucosal vaccine design.
@ast
Vibrio cholerae: lessons for mucosal vaccine design.
@en
Vibrio cholerae: lessons for mucosal vaccine design.
@nl
P2860
P356
P1476
Vibrio cholerae: lessons for mucosal vaccine design.
@en
P2093
Andrew Camilli
Anne L Bishop
P2860
P356
10.1586/ERV.10.150
P577
2011-01-01T00:00:00Z